Literature DB >> 7667983

Outpatient treatment of adult asthma.

E C Kleerup1, D P Tashkin.   

Abstract

As a chronic disease with intermittent exacerbations, asthma is treated primarily in the outpatient setting by primary care physicians. Asthma is the result of complex and only partially understood interactions of respiratory, inflammatory, and neural cells and their mediators. The goals of asthma therapy are to prevent and relieve symptoms, allow normal activities of daily living, restore and maintain normal pulmonary function, avoid adverse effects from interventions, and minimize inconvenience and cost. These goals can be achieved through educating patients, assessing and monitoring asthma severity, avoiding or controlling asthma triggers, establishing an intervention plan for routine self-management and the management of exacerbations, and providing regular follow-up care. We present a stepped approach to asthma pharmacotherapy, emphasizing anti-inflammatory therapy--inhaled corticosteroids, cromolyn sodium, or nedocromil sodium--as a summary of recent national and international recommendations.

Entities:  

Mesh:

Year:  1995        PMID: 7667983      PMCID: PMC1302916     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  44 in total

Review 1.  "Helper" (CD4+) T cells and eosinophils in allergy and asthma.

Authors:  A B Kay
Journal:  Am Rev Respir Dis       Date:  1992-02

Review 2.  Patient use of peak flow monitoring.

Authors:  N M Clark; D Evans; R B Mellins
Journal:  Am Rev Respir Dis       Date:  1992-03

Review 3.  Mechanisms of airway inflammation.

Authors:  R F Lemanske
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

Review 4.  Biologic effects of mast cell enzymes.

Authors:  J A Nadel
Journal:  Am Rev Respir Dis       Date:  1992-02

Review 5.  Regulation of neurogenic inflammation by neutral endopeptidase.

Authors:  J A Nadel
Journal:  Am Rev Respir Dis       Date:  1992-02

Review 6.  New concepts about the mast cell.

Authors:  S J Galli
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

7.  Auranofin in the treatment of steroid dependent asthma: a double blind study.

Authors:  G Nierop; W P Gijzel; E H Bel; A H Zwinderman; J H Dijkman
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 8.  Nocturnal asthma: circadian rhythms and therapeutic interventions.

Authors:  R J Martin
Journal:  Am Rev Respir Dis       Date:  1993-06

9.  A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids.

Authors:  H S Nelson; D L Hamilos; P R Corsello; N V Levesque; A D Buchmeier; B L Bucher
Journal:  Am Rev Respir Dis       Date:  1993-02

10.  Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.

Authors:  A G Alexander; N C Barnes; A B Kay
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

View more
  2 in total

1.  Asthma therapy--future promise and current practice.

Authors:  H A Boushey
Journal:  West J Med       Date:  1995-07

2.  Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.

Authors:  Carlyne M Averell; François Laliberté; Guillaume Germain; Mei Sheng Duh; Matthew D Rousculp; Sean D MacKnight; David J Slade
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.